Connect with us

Cannabis News

U.S. Senate Committee To Hold Hearing On Benefits Of Psychedelics For Military Veterans

Published

on

The U.S. Senate Commission has heard “alternative therapies” for military veterans, many witnesses expected to discuss therapeutic benefits of psychedelic.

Field hearing will be excluded from Capitol, including the Commission of Veteran Senate Affairs in Montevallo, Alabama, Friday, veteran and psychedelic mental health treatment.

Witnesses are an officer for veteran issues (VA), coalition of veteran health care coalition Adam Marr, Compass pathways at Steve Levine, University of Alabama in Brian Schiefer (SCI-DI).

“This is a call for action. Veterans don’t break the system,” The marijuana moments said on Thursday Thursday. “VA makes some good things, but what they don’t do well are these new innovations and have approaches to bring them.”

Writing the testimony to be submitted to the committee “alternative therapies” said “, therefore,” therapies are being created or psychedelic, psilocybin, dmt, 5-meo-dmt, Methylon. “

“In general, these therapies of psychedelic therapies are also fast and solid symptoms offer rapid and strong improvements.

“Despite the promising results, psychedelic therapies face the regulatory research barriers” and the access said in the testimony. It also said that “difficult understanding” is why federal federations only offered “minimum” funding to support research on therapeutic benefits of substances.

Most witnesses selected hearing They have somehow been psychedelic research and defense.

For example, Ixse Wiechers, Director General of Veterans Health Administration (VHA), was among the authors of a 2024 report among the authors of research on research and implementation of psychedelic research research on VA 2024.

Levine serves as a director of patients compass, a biotechnology research company specializing in Psychodelics, who helped protect a nomination of the Psilocybin of the Food and Drug Administration (FDA).

Schiefer also promotes the therapeutic benefits of psychedelic medicine as the role of SCI-DI to spread access to alternative therapies for veterans with severe mental and physical conditions with severe mental and physical conditions.

Notable, in the situation of a member of the Audition Committee, Tommy Tuberville (R-al), who has provided support for the Canavy Industry Bank But it is not particularly proactive in the face of psychedelic reform.

The meeting of the Senate is broader in Congress carefully to the subject. On both sides of Congress, as well as key officials of the administration to deform reform.

For example, Vako’s head recently He assumed his role to promote access to psychedelic access to veterans With serious mental health conditions, it was possible to open “wider than thought that door”.

VA Secretary Doug Collins, who He has raised attention to the President Donald TrumpHe said, “We will do the right way,” Ibogaine, MDMA and PSilocybin to face the clinical trials that are being investigated.

Last month, the Secretary also confirmed “Very open” to spread access to psychedelic therapy for veterans-Massionate that people with serious mental health conditions intend to find “healing” ways and not only treat surface symptoms.

Collins pointed out that VA is actively performed through internal or private cooperation in clinical trials “actually results in different substances that are good results”, including One is investigating a supported MDMA-based therapy based on VA Bronx health care “Actually, good results.”

In that conversation, it was also Collins He showed the last clip of the army stamps in Rob O’Neill, who killed Osama bin Laden, The federal government intentionally avoided his theory, because he has prevented access to psychedelic medicine, because cures are more profitable than long-term treatments. Collins replied in response: “I will tell you right now: this secretary of veterans, myself, I want to heal people.”

In the meantime, the GOP-controlled household board approved a change attached to the defense invoice “Progress Report” is required in a Psychedelic Pilot Therapy program For active duty for military service members and veterans.

However, the Congress has been a research proposal for psychedelic research in recent sessions, last week, has blocked a change of bipartisan bipartisa (R-TX) that would provide another $ 10 million. Clinical essays in therapeutic potential of substances like ibogaine and psilocybin in the therapeutic potential of clinical support.


Marijuana is a moment Monitoring of hundreds of cannabis, psychedelic and drug policy invoices This year’s state legislatures and congresses. Patreon supporters At least $ 25 / monthly enter our interactive maps, graphs and listening to the listening calendar, so they do not lose development.


Learn more about us Marihuana Bill Tracker and become Assistant Patreon to get access.

One by one, Bipartisan Congress legislators met with VA secretary Discuss paths to access psychedelic medicine As an alternative treatment for conditions like PTSD.

After Meeting by asking for Collins In May, reps. Lou Correa (D-CA) and Jack Bergman (R-Mi) The chairs of psychedelic psychedelic psychedelic psychedelics (path) Caucus said three.

Collins, in particular, is highlighted as VA Secretariat for Sustnator, which explores the potential of Ubogaine and MDMA, providing relief of serious mental health conditions, Robert F. Kennedy Jr., HHS head, is his goal. Release plant-based medicine options within 12 months.

New Gingrich (R-GA) separated the former speaker of the US Psychedelic Ibogaine is a “amazing breakthrough” The current “patient care system” has left people with serious mental health conditions, unintentionally intended by alternative treatment options, and intends to use its impact on the problem.

One by one, he entered the change of expenditure invoices in Correa and BergmanResearch on the benefits of psychedelic treatment to treat medical conditions It usually affects military veterans.

Legislators separated the bill in April to provide $ 30 million each year Establish psychedelic by the “Centers for Excellence” at VA FacilitiesVeterans to receive an innovative treatment that contains substances such as Psilocybin, MDMA and Ibogaine.

Collins, for his part, also known in April he had “open eye” with Kennedy About the therapeutic potential of psychedelic medicine. And he said that the government is open to the idea of ​​giving boots to cover the costs of psychedelic therapy for veterans who receive external services from VA. As a congress.

Bergman also has Advanced Psychedelic Reform Opportunity to advance through TrumpThe administration argues that federal expenditure and the efforts will give the “spine” agencies to deal with complex problems.

Kennedy, for his part, also said in April Had “wonderful experience” with LSD in 15 yearsHe thought he could see the dinosaurs, as he portrayed in a comic book.

Last October, Kennedy criticized the FDA “Psychodelics Support” of the Agency and said the laundry of other issues.

In December, VA reported individually to finance $ 1.5 million to finance Learn the effectiveness of therapy assisted by MDMA for veterans PTSD and alcohol use disorder (AUD).

Last year, VA Yehuda also financed the initial examination agency “Amazing and strong results” from the first clinical test of MDMA therapy.

In January, Shereef Elnahah Bed secretary was VA (it was very gratifying) Trump said Kennedy Lead HHS protected Psychedelics reform. And he He hoped to work with him For the next administration, but that did not come out.

Marijuana is possible with the help of readers. If you are based on journalism to defend cannabis, consider the commitment to Patreon every month.

Become patreon guard!

(Tagstotranslate) highlighted

Continue Reading

Cannabis News

Speakeasy Dispensary announces opening of newest Kentucky location

Published

on

By

Speakeasy Dispensary will officially open its newest medical cannabis location in Kentucky at 108 E. Main St., Princeton, KY 42445, further expanding access to patients in Caldwell County and surrounding communities.

The dispensary will open at 11:00 a.m. on Friday, April 10 for registered medical cannabis patients.

Located in the heart of downtown Princeton, the space reflects Speakeasy’s vision to blend local character and a comfortable, patient-first experience. The carefully designed environment provides a welcoming entrance before patients enter the main sales floor, where trained team members provide personalized guidance and education tailored to the individual’s needs.

“Each new location is an opportunity to meet patients where they are,” said Casey Flippo, CEO of Gold Leaf Management. “Communities like Princeton are an important part of Kentucky’s medical cannabis program, and expanding access here means more patients can explore safe and regulated options closer to home. As the program continues to take shape, our focus remains on building something reliable, accessible and rooted in long-term care.”

Opening weekend will feature a low-cost patient drive, offering new and existing patients an affordable and streamlined way to obtain or renew their Kentucky cannabis license.

© Speakeasy Dispensary

In partnership with the Kentucky Cannabis Industry Association and LexMed & Wellness, patient tours will be held Friday, April 10th from 11:00am to 7:00pm and Saturday, April 11th from 11:00am to 5:00pm. Appointments will be made with a licensed provider in a mobile unit on site, so patients can complete the entire process, including assessment, notary and state filing, in one visit.

Patients can register for an appointment by clicking here. The appointment fee is $25, and an additional $25 state fee must be paid when submitting documents to the state portal. The $25 state fee is waived for anyone who received a valid medical card in 2025.

As Kentucky’s medical cannabis market continues to develop, product availability and selection will continue to grow along with additional growers and processors entering the space. In addition to flowers and gummies, Speakeasy Princeton plans to have an extensive menu soon after opening, which will include vapes and concentrates, along with a new variety of gummies. Speakeasy continues to focus on providing a consistent education-first experience supported by strong statewide partnerships.

For more information:
Speakeasy Dispensary
speakeasydispensaries.com/

Continue Reading

Cannabis News

West Virginia Treasurer Allocates Medical Marijuana Revenue Despite Governor’s Veto

Published

on

By

“The issue is not whether the funds should be used, but how they are used and how we are doing it in a responsible and sustainable way.”

By Henry Culvyhouse, Mountain State Spotlight

This story was originally published by Mountain State Spotlight. Get stories like this delivered to your email inbox once a week; sign up for the free newsletter at https://mountainstatespotlight.org/newsletter.

Even with the veto he could have delayed it further $38 million spent on medical marijuana raised over the past four years, state Treasurer Larry Pack (R) now says he will release the funds during his original term.

Last week, Gov. Patrick Morrisey (R) vetoed a bill that would have required the release of medical marijuana funds to help the homeless and expedite child abuse and neglect cases in the court system. He said the bill tied up money for future expenses.

In his veto letter, Morrisey wrote, “West Virginia needs to do a better job of planning for the future, and cannot fully pre-commit future revenue like this if it has reserves to invest more in roads, water, sewer, site selection, rail and future tax cuts.”

Morrisey said he was willing to negotiate with the Legislature on how to spend the money.

“The issue is not whether the funds should be used, but how they are used and whether we are doing so responsibly and sustainably,” Lars Dalseide, a spokesman for the governor’s office, wrote in an email.

But the money was pre-committed in state code.

Pack’s office said 100 percent of that money will go to various offices and programs mandated by the original law; more than half to the Office of Medical Cannabis, with the remaining funds split between the substance abuse treatment grant program and law enforcement grants. The move negates the governor’s desire to use future reserves to deal with infrastructure and tax cuts.

In October, a Mountain State Spotlight investigation revealed that $34 million was deposited into an account held by the Treasury Department from the state’s medical marijuana program..

Pack’s office said the money it was not spent due to legal concerns about the drug. Currently, marijuana is listed as a Schedule I narcotic under federal law, meaning it has no medical use and is illegal.

Pack is not the first state treasurer to express concern. State Treasurer John Perdue (D) said his office would not keep money in 2018 after the Medical Cannabis Act was passed. Riley Moore (R), who beat Perdue in the 2020 race, never released the money.

In the 2026 Legislative Session, Del. Rep. Evan Worrell, R-Cabell, said he read a report on the funds raised and wanted to change it. He successfully led a bill that would have forced the state to spend money on a commission to help thousands of children with abuse and neglect in court and homelessness services.

Had the governor not vetoed the bill, the money would have been earmarked for one year for those things. The commission on substance abuse research, treatment, and abuse and neglect would continue for years to come.

Treasurer’s Office spokeswoman Carrie Smith said that due to the complexity of state and federal laws, the office had been working for months to release the money. He said that the money has been sent to the Department of Security and the Department of Health.

This the article appeared for the first time The focus of the Mountain State and is republished here under a Creative Commons Attribution-NoDerivs 4.0 International License.

Marijuana Moment is made possible with the help of readers. If you rely on our pro-cannabis journalism to stay informed, consider a monthly Patreon pledge.

Become a patron on Patreon!

Continue Reading

Cannabis News

Critical updates for cannabis taxpayers as the 2025 filing deadline approaches

Published

on

By











With the April 2025 tax return filing deadline fast approaching, cannabis companies must once again face the burden of Section 280E of the Internal Revenue Code (“Section 280E”). Despite significant developments over the past year — including a major executive order from President Trump and the IRS, for the first time, disclosing legal reasoning funds to keep state cannabis “within the meaning” of Section 280E — taxpayer scrutiny remains the same.

However, whether substantively or psychologically, these recent developments weigh on how taxpayers should deal with Section 280E. Below, we summarize the key developments that cannabis taxpayers should be aware of as they prepare their 2025 returns.

As discussed in previous publications, Section 280E provides: “(e) no deduction or credit shall be allowed for any amount paid or incurred in the course of any trade or business during the taxable year, if such trade or business (or the activities constituting such trade or business) is trafficking in controlled substances (controlled substance classes I and II prohibited by State or Federal law).

Because cannabis is now listed as a Schedule I controlled substance under the Controlled Substances Act (CSA), the IRS has consistently maintained that Section 280E applies to state-licensed cannabis businesses, significantly increasing their effective tax rates.

Read more at JD above










Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media